Amr Nashaat Esmail

Dr. Amr Nashaat Esmail


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
SASara Amer Alomar
Sara Amer Alomar
AAAhmed Nawfal Alshammari
Ahmed Nawfal Alshammari
FAFahad Alnajim
Fahad Alnajim
MAMaan Abdullah Albehair
Maan Abdullah Albehair
AEAmr Nashaat Esmail
Amr Nashaat Esmail
Mohammed Shahab UddinMohammed Shahab Uddin
Mohammed Shahab Uddin
Background: Magnetic Resonance Imaging (MRI) is essential in pediatric diagnostics; however, the need for effective sedation due to children’s inability to remain still presents a challenge. Oral Chloral Hydrate (OCH) is commonly used for its efficacy and safety, but there is a lack of detailed exploration of the median induction time, the period from administration to effective sedation. This study aimed to evaluate the efficacy of OCH and identify the determinants of the median induction time for pediatric MRI procedural sedation.Methods: This retrospective study evaluated oral chloral hydrate (50-100 mg/kg) for pediatric MRI sedation using records from the Imam Abdulrahman Bin Faisal Hospital (2018-2022). Pediatric patients (1–8 years) were assessed for sedation efficacy, with exclusion criteria for allergies or incomplete data. Time-to-event analysis (Kaplan–Meier and Cox regression) was used to identify factors influencing sedation induction time. The data included age, weight, dose, and outcomes. The analysis highlighted the key predictors of sedation success and optimized procedural sedation protocols.Results: The study included 183 pediatric patients with a median age of 30 months and a median chloral hydrate dose of 66 mg. Sedation success was 85.79%, with younger age and shorter induction times being significantly associated with success (p<0.001). Kaplan-Meier analysis showed no significant difference in induction times between the neurological and non-neurological groups (p=0.64). Cox regression identified longer MRI duration and multiple doses as significant factors influencing the timing of sedation (p=0.050, p=0.008). Bootstrap analysis confirmed a robust median induction time of 30 minutes.Conclusions: Oral chloral hydrate achieved 85.79% success in pediatric MRI sedation, with younger and lighter patients having better outcomes. The median sleep induction time was 30 minutes, and extending sedation to 60 minutes further improved the success rate.

13 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Mohammed Shahab UddinMohammed Shahab Uddin
Mohammed Shahab Uddin
FAFayes Alshammari
Fayes Alshammari
AEAmr Nashaat Esmail
Amr Nashaat Esmail
KSKhaled Shafeen
Khaled Shafeen
FAFahad Alnajim
Fahad Alnajim
MQMaryam Al Qannas
Maryam Al Qannas
Background: Infantile dilated cardiomyopathy (DCM) is uncommon but carries substantial mortality, particularly when accompanied by neurological, ocular, or metabolic abnormalities. Long-Olsen-Distelmaier syndrome is a rare mTORopathy caused by heterozygous gain-of-function variants in RRAGC and may include cortical malformations, congenital cataracts, mineral disturbances, and early-onset DCM. Case Summary: We describe a term male infant born to consanguineous parents who developed hypocalcemia with hyperphosphatemia, bilateral frontoparietal polymicrogyria, bilateral congenital lamellar cataracts, and small patent ductus arteriosus and ventricular septal defect with initially preserved biventricular function. Consequently, clinical whole-exome sequencing was requested. At 53 days of age, he presented with poor feeding, lethargy, cardiogenic shock, severe lactic acidosis, and hyperkalemia during a rhinovirus/enterovirus-positive respiratory illness. Echocardiography demonstrated newly developed severe DCM, marked left ventricular dilatation, and an ejection fraction of 27%. Despite multi-agent inotropic support and intensive care, ventricular function did not recover, and he died at approximately two months of age. Whole-exome sequencing identified a heterozygous RRAGC NM_022157.4:c.343T>C, p.(Trp115Arg) variant. The diagnostic laboratory classified the variant as likely pathogenic, and an independent manuscript-level ACMG/AMP reassessment was concordant. The multisystem phenotype was also highly consistent with the reported syndrome. Conclusion: This case broadens the clinical and geographic spectrum of RRAGC-related Long-Olsen-Distelmaier syndrome and documents rapid progression from preserved neonatal ventricular function to fatal infantile DCM. Moreover, respiratory viral detection should be interpreted cautiously because myocardial infection or myocarditis was not established. Early exome-based testing should be considered in infants with cardiomyopathy and multi-system abnormalities.

12 September 2026 in Genes
Verified
Journal Article
Open access
PDF file
Mohammed Shahab UddinMohammed Shahab Uddin
Mohammed Shahab Uddin
FAFayez AlShammari
Fayez AlShammari
AEAmr Nashaat Esmail
Amr Nashaat Esmail
KSKhaled Shafeen
Khaled Shafeen
FAFahad Alnajim
Fahad Alnajim
MQMaryam Al Qannas
Maryam Al Qannas
Background: Infantile dilated cardiomyopathy (DCM) is uncommon but carries substantial mortality, particularly when accompanied by neurological, ocular, or metabolic abnormalities. Long–Olsen–Distelmaier syndrome is a rare mTORopathy caused by heterozygous gain-of-function variants in RRAGC and may include cortical malformations, congenital cataracts, mineral disturbances, and early-onset DCM. Case Summary: We describe a term male infant born to consanguineous parents with hypocalcemia and hyperphosphatemia, bilateral frontoparietal polymicrogyria, bilateral congenital lamellar cataracts, small patent ductus arteriosus and ventricular septal defect, and initially preserved biventricular function. At 53 days of age, he developed cardiogenic shock, severe lactic acidosis, and hyperkalemia during a rhinovirus/enterovirus-positive respiratory illness. Echocardiography showed severe DCM with marked left ventricular dilatation and an ejection fraction of 27%. Despite multi-agent inotropic support, ventricular function did not recover, and he died at approximately two months. Accordingly, the contemporaneous clinical WES record documented a heterozygous RRAGC c.343T>C, p.(Trp115Arg) variant, reported by the diagnostic laboratory as likely pathogenic. The variant was subsequently standardized in this manuscript as NM_022157.4:c.343T>C, and an independent manuscript-level ACMG/AMP reassessment was concordant. Conclusions: Because p.(Trp115Arg) was previously reported, the principal contribution is detailed documentation of rapid progression from preserved neonatal ventricular function to fatal infantile DCM, while extending the clinical and geographic spectrum of RRAGC-related Long–Olsen–Distelmaier syndrome. Respiratory viral detection should be interpreted cautiously because myocarditis was not established; early exome-based testing should be considered in infants with cardiomyopathy and multisystem abnormalities.

12 April 2026 in Genes
Verified
Journal Article
Open access
PDF file
Mohammed Shahab UddinMohammed Shahab Uddin
Mohammed Shahab Uddin
YAYasmeen Alnamshan
Yasmeen Alnamshan
KSKhaled Shafeen
Khaled Shafeen
SJSyeda Nilofer Jahan
Syeda Nilofer Jahan
NANora AlMadhi
Nora AlMadhi
MQMaryam Al Qannas
Maryam Al Qannas
Background/Objectives: Infantile cardiomyopathy is a rare but often life-threatening condition in which monogenic causes are particularly relevant, especially when cardiac disease is preceded by hypotonia or multisystem involvement. Among sarcomeric genes, MYL2, encoding the ventricular regulatory myosin light chain, plays a critical role in myocardial contractility. However, biallelic MYL2-associated disease remains exceptionally rare, and its clinical spectrum is not fully defined. This study aims to describe a novel case and further delineate the phenotype of recessive MYL2-related cardiomyopathy. Methods: We report a male infant with congenital hypotonia and delayed motor development who underwent extensive metabolic, neuromuscular, and neuroimaging evaluation. Trio-based whole-exome sequencing was performed to identify a potential genetic etiology, followed by variant interpretation using standard bioinformatic and ACMG/AMP criteria. Results: The patient developed acute decompensated heart failure at approximately 10 months of age, with severe left ventricular systolic dysfunction and multiorgan failure, and died at 12 months despite maximal intensive care support. Whole-exome sequencing identified a homozygous MYL2 c.413T>A (p.Met138Lys) missense variant. The variant is absent or extremely rare in population databases, affects a highly conserved residue, is predicted to be deleterious by multiple in silico tools, and is compatible with autosomal recessive inheritance, with both parents confirmed as heterozygous carriers. In the context of a phenotype consistent with recessive MYL2-associated disease, these findings support a likely pathogenic interpretation. Conclusions: This case expands the allelic and phenotypic spectrum of recessive MYL2-associated cardiomyopathy and highlights the value of early genomic testing in infants with unexplained hypotonia and rapidly progressive cardiac dysfunction. Molecular diagnosis may aid in prognosis, clinical decision-making, and genetic counseling.